Bioventus (BVS) Net Income (2020 - 2026)

Bioventus (BVS) has 6 years of Net Income data on file, last reported at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income rose 218.78% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $34.5 million (up 1139.8% YoY), and the FY2023 full-year result was -$74.4 million, down 8.28% from the prior year.
• Net Income for Q1 2026 stood at $3.9 million, down from $17.3 million in the prior quarter.
• Across five years, Net Income topped out at $17.3 million in Q4 2025 and bottomed at -$74.4 million in Q2 2023.
• The 4-year median for Net Income is -$340500.0 (2022), against an average of -$11.2 million.
• The widest annual swing landed in 2022, when Net Income slumped 93484.0%; it then jumped 218.78% in 2026.
• A 4-year view of Net Income shows it stood at -$23.4 million in 2022, then tumbled by 218.13% to -$74.4 million in 2023, then jumped by 123.27% to $17.3 million in 2025, then plunged by 77.21% to $3.9 million in 2026.
• The last three Net Income figures came in at $3.9 million (Q1 2026), $17.3 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.

Peer Comparison